SCHEMBL4895884

SCHEMBL4895884

CCN(c1ccc(NS(=O)(=O)c2ccc(C(F)(F)F)cc2)cc1)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 3/20 0.48
HDAC3 O15379 2/20 0.48
HDAC11 Q96DB2 2/20 0.48
HDAC6 Q9UBN7 2/20 0.48
NPSR1 Q6W5P4 2/20 0.48
SERPINE1 P05121 2/20 0.46
BRD4 O60885 1/20 0.46
HIF1A Q16665 1/20 0.46
MEN1 O00255 1/20 0.45
ALOX15 P16050 1/20 0.45
MAPK1 P28482 1/20 0.45
KMT2A Q03164 1/20 0.45
POLB P06746 2/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC9 Q9UKV0 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906833 0.92 HDAC3 (0.47) HDAC8HDAC3HDAC11HDAC6NPSR1
SCHEMBL4904061 0.91 SERPINE1 (0.50) HDAC8HDAC3HDAC11HDAC6NPSR1
SCHEMBL4905415 0.90 ALDH1A1 (0.50) NPSR1BRD4MEN1MAPK1KMT2A
SCHEMBL4894519 0.89 HDAC8 (0.52) HDAC8HDAC3HDAC11HDAC6NPSR1
SCHEMBL4905920 0.88 HDAC8 (0.54) HDAC8HDAC3HDAC11HDAC6NPSR1
SCHEMBL4906502 0.88 HDAC8 (0.50) HDAC8HDAC3HDAC11HDAC6NPSR1
SCHEMBL4899758 0.84 MMP2 (0.49) HDAC8HDAC3HDAC11HDAC6NPSR1
SCHEMBL4902866 0.82 HDAC8 (0.56) HDAC8HDAC3HDAC11HDAC6NPSR1
SCHEMBL5371871 0.82 MEN1 (0.57) BRD4MEN1ALOX15MAPK1KMT2A
SCHEMBL4904216 0.82 PTPN5 (0.53) HDAC8HDAC3HDAC11HDAC6MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD HDAC8 959/4885HDAC3 176/4885HDAC11 718/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD HDAC8 882/4885HDAC3 157/4885HDAC11 657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.